Literature DB >> 4363038

Protective immunity to amebic infection demonstrated in guinea pigs.

I M Krupp.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4363038     DOI: 10.4269/ajtmh.1974.23.355

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


× No keyword cloud information.
  8 in total

Review 1.  Progress towards development of a vaccine for amebiasis.

Authors:  S L Stanley
Journal:  Clin Microbiol Rev       Date:  1997-10       Impact factor: 26.132

2.  Alterations of humoral, cell mediated and antibody dependent cell mediated cytotoxic responses during the course of amoebic infection in guinea pigs.

Authors:  V K Vinayak; A Saxena; A K Malik
Journal:  Gut       Date:  1987-10       Impact factor: 23.059

3.  Progress report intestinal protozoa.

Authors:  R Knight; S G Wright
Journal:  Gut       Date:  1978-10       Impact factor: 23.059

4.  Morphology of the spleen and lymph nodes in fatal visceral leishmaniasis.

Authors:  B Veress; A Omer; A A Satir; A M El Hassan
Journal:  Immunology       Date:  1977-11       Impact factor: 7.397

5.  Cloning and expression of a membrane antigen of Entamoeba histolytica possessing multiple tandem repeats.

Authors:  S L Stanley; A Becker; C Kunz-Jenkins; L Foster; E Li
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

6.  Vaccination of rabbits against Entamoeba histolytica with aqueous suspensions of trehalose-dimycolate as the adjuvant.

Authors:  A Sharma; A Haq; S Ahmad; E Lederer
Journal:  Infect Immun       Date:  1985-06       Impact factor: 3.441

7.  Protection of gerbils from amebic liver abscess by immunization with the galactose-specific adherence lectin of Entamoeba histolytica.

Authors:  W A Petri; J I Ravdin
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

8.  Protection of gerbils from amebic liver abscess by immunization with a recombinant Entamoeba histolytica antigen.

Authors:  T Zhang; P R Cieslak; S L Stanley
Journal:  Infect Immun       Date:  1994-04       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.